CN109568472A - 一种治疗胃炎的中药配方及其制备方法 - Google Patents
一种治疗胃炎的中药配方及其制备方法 Download PDFInfo
- Publication number
- CN109568472A CN109568472A CN201910093345.9A CN201910093345A CN109568472A CN 109568472 A CN109568472 A CN 109568472A CN 201910093345 A CN201910093345 A CN 201910093345A CN 109568472 A CN109568472 A CN 109568472A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chinese
- medicine
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 131
- 238000002360 preparation method Methods 0.000 title claims abstract description 58
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 56
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 42
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 42
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 42
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 42
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 40
- 235000008434 ginseng Nutrition 0.000 claims abstract description 40
- 239000009636 Huang Qi Substances 0.000 claims abstract description 38
- 241000143476 Bidens Species 0.000 claims abstract description 37
- 235000010662 Bidens pilosa Nutrition 0.000 claims abstract description 37
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims abstract description 36
- 210000003038 endothelium Anatomy 0.000 claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 28
- 229920001661 Chitosan Polymers 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 19
- 235000013343 vitamin Nutrition 0.000 claims abstract description 19
- 239000011782 vitamin Substances 0.000 claims abstract description 19
- 229940088594 vitamin Drugs 0.000 claims abstract description 19
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 238000004140 cleaning Methods 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims description 36
- 241001247821 Ziziphus Species 0.000 claims description 34
- 240000006079 Schisandra chinensis Species 0.000 claims description 30
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 30
- 241000123107 Phellinus Species 0.000 claims description 26
- 239000003651 drinking water Substances 0.000 claims description 23
- 235000020188 drinking water Nutrition 0.000 claims description 23
- 238000009835 boiling Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 238000007654 immersion Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000000717 retained effect Effects 0.000 claims description 5
- 241000842328 Bidens bipinnata Species 0.000 claims description 4
- 241001251949 Xanthium sibiricum Species 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- 241000219793 Trifolium Species 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 11
- 241000219823 Medicago Species 0.000 claims 10
- 230000000694 effects Effects 0.000 abstract description 41
- 240000004658 Medicago sativa Species 0.000 abstract description 28
- 208000002193 Pain Diseases 0.000 abstract description 22
- 230000036407 pain Effects 0.000 abstract description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 13
- 210000001156 gastric mucosa Anatomy 0.000 abstract description 12
- 230000029087 digestion Effects 0.000 abstract description 9
- 230000004224 protection Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 5
- 230000002496 gastric effect Effects 0.000 abstract description 5
- 230000036592 analgesia Effects 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 238000011084 recovery Methods 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000000116 mitigating effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 28
- 210000002784 stomach Anatomy 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 16
- 230000006870 function Effects 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 14
- 241000700159 Rattus Species 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 8
- 229930182490 saponin Natural products 0.000 description 8
- 150000007949 saponins Chemical class 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 7
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 7
- -1 triterpene compound Chemical class 0.000 description 7
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000001151 other effect Effects 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 4
- 108010065511 Amylases Proteins 0.000 description 4
- 102000013142 Amylases Human genes 0.000 description 4
- 241001149422 Ganoderma applanatum Species 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 4
- 235000019418 amylase Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 229910052732 germanium Inorganic materials 0.000 description 4
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 3
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 3
- 208000031091 Amnestic disease Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 239000004380 Cholic acid Substances 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000006986 amnesia Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 235000019416 cholic acid Nutrition 0.000 description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 3
- 229960002471 cholic acid Drugs 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- UGMQOYZVOPASJF-OXUZYLMNSA-N (2r)-2-[(3s,5r,10s,13r,14r,17r)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@@H](CCC(=C)C(C)C)C(O)=O)CC[C@]21C UGMQOYZVOPASJF-OXUZYLMNSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- CJPXZAMCIOOMNF-UHFFFAOYSA-N Lucernol Chemical compound C1=C(O)C(O)=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 CJPXZAMCIOOMNF-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 235000010624 Medicago sativa Nutrition 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000235342 Saccharomycetes Species 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229960001301 amobarbital Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 108010089934 carbohydrase Proteins 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 210000001809 melena Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 2
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 2
- 206010034674 peritonitis Diseases 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001197 polyacetylene Polymers 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000036578 sleeping time Effects 0.000 description 2
- 230000008925 spontaneous activity Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000002522 swelling effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- NUNODKNZSZKXGY-LBPRGKRZSA-N (2s)-5,7,8-trihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=C(O)C(O)=CC(O)=C2C(=O)C1 NUNODKNZSZKXGY-LBPRGKRZSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000270955 Achnatherum calamagrostis Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 241000842326 Bidens parviflora Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 241001674939 Caulanthus Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010070814 Corrosive gastritis Diseases 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- RTZKSTLPRTWFEV-OLZOCXBDSA-N Deoxygomisin A Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H](C)[C@@H](C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-OLZOCXBDSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- UGMQOYZVOPASJF-UHFFFAOYSA-N Eburicoinsaeure Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)CCC21C UGMQOYZVOPASJF-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- 206010017866 Gastritis haemorrhagic Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- RTZKSTLPRTWFEV-UHFFFAOYSA-N Isokadsuranin Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC(C)C(C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010061297 Mucosal erosion Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000254223 Syntexis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940058573 b-d glucose Drugs 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 1
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- NUNODKNZSZKXGY-UHFFFAOYSA-N isocarthamidin Natural products C1=CC(O)=CC=C1C1OC2=C(O)C(O)=CC(O)=C2C(=O)C1 NUNODKNZSZKXGY-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 201000003102 mental depression Diseases 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940087004 mustargen Drugs 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930192961 schisandrol Natural products 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 229930190376 scutellarin Natural products 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药技术领域,公开了一种治疗胃炎的中药配方,包括以重量份计算的山药70‑90份、柴胡30‑45份、川芎20‑30份、神曲40‑60份、云苓10‑20份、鸡内金10‑20份、人参20‑30份、黄芪30‑50份、红枣50‑60份、鬼针草20‑30份、紫苜蓿30‑50份。本发明还公开了上述一种治疗胃炎的中药配方的制备方法,通过原料的清洗、煎药、药品混合、分装得到成品。本发明的配方具有促进消化、缓解胃胀、镇痛、消炎、促进胃粘膜再生、保护胃粘膜、抑菌、增强免疫力等作用。在传统中药的基础上添加了维生素U、壳聚糖,用于促进胃粘膜的再生和保护胃粘膜,有利于提高药效。同时还能缓解疼痛,有利于减轻患者在患病过程中所遭受的痛苦,有利于减轻病人的心理压力,有利于疾病的恢复。
Description
技术领域
本发明属于中药技术领域,具体涉及一种治疗胃炎的中药配方及其制备方法。
背景技术
胃炎是各种原因引起的胃黏膜炎症,为最常见的消化系统疾病之一。按临床发病的缓急,一般可分为急性胃炎和慢性胃炎两大类型。最常见的急性胃炎为急性单纯性胃炎,主要表现为上腹痛、腹胀、嗳气、食欲减退、恶心、呕吐等。有沙门菌或金黄色葡萄球菌毒素所致者,多伴有腹泻、发热,甚至脱水、休克。急性糜烂出血性胃炎可有呕血和黑便。急性化脓性胃炎则以全身败血症和急性腹膜炎为主要临床表现。急性腐蚀性胃炎症状最为明显,表现为吞服腐蚀剂后口腔、咽喉、胸骨后、上腹部的剧痛,伴恶心呕吐,甚至呕血。唇、口腔、咽喉黏膜可产生颜色不同的灼痂,有助于各种腐蚀剂的鉴别。慢性胃炎缺乏特异性症状,症状的轻重与胃黏膜的病变程度并非一致。大多数病人常无症状或有程度不同的消化不良症状如上腹隐痛、食欲减退、餐后饱胀、反酸等。慢性萎缩性胃炎患者可有贫血、消瘦、舌炎、腹泻等,个别病人伴黏膜糜烂者上腹痛较明显,并可有出血,如呕血、黑便。症状常常反复发作,无规律性腹痛,疼痛经常出现于进食过程中或餐后,多数位于上腹部、脐周、部分患者部位不固定,轻者间歇性隐痛或钝痛、严重者为剧烈绞痛。
现有的一些中药配方虽然能够治愈胃炎,但是大多缺乏止痛作用,且病人的治愈时间较长。而病人因治愈之间长、疼痛等原因,常常心理压力较大,精神抑郁或过度紧张和疲劳,容易造成幽门括约肌功能紊乱,胆汁反流而导致病情加重。且现有的中药配方中保护胃粘膜的有效成分较少,对胃粘膜的保护、修复效果不明显,病灶的去除较慢。
发明内容
为了解决现有技术存在的上述问题,本发明目的在于提供一种具有止痛效果、治疗时间较短、治疗效果较好的治疗胃炎的中药配方及其制备方法。
本发明所采用的技术方案为:
一种治疗胃炎的中药配方,其特征在于:包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份。
进一步的,所述治疗胃炎的中药配方还包括五味子份、陈皮份和佛手份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份。
进一步的,所述治疗胃炎的中药配方还包括桑黄份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份。
进一步的,所述治疗胃炎的中药配方还包括半枝莲份、平盖份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份。
进一步的,所述治疗胃炎的中药配方还包括维生素U份、壳聚糖份和大麦芽份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、维生素U0.5-1.5份、壳聚糖1-2份、大麦芽15-30份。
进一步的,包括以重量份计算的山药85份、柴胡30份、川芎25份、神曲37份、云苓19份、鸡内金15份、人参25份、黄芪35份、红枣55份、鬼针草26份、紫苜蓿36份。
进一步的,所述治疗胃炎的中药配方还包括维生素U份、壳聚糖份和大麦芽份,所述治疗胃炎的中药配方包括以重量份计算的山药83份、柴胡35份、川芎25份、神曲42份、云苓17份、鸡内金15份、人参23份、黄芪40份、红枣54份、鬼针草23份、紫苜蓿41份、五味子15份、陈皮15份、佛手25份、桑黄26份、半枝莲25份、平盖8份、维生素U1份、壳聚糖1.5份、大麦芽25份。
进一步的,制备上述的一种治疗胃炎的中药配方,具体制备步骤如下:
S1.原料清洗:分别将山药、柴胡、川芎、神曲、云苓、鸡内金、人参、黄芪、红枣、鬼针草、紫苜蓿、五味子、陈皮、佛手、桑黄、半枝莲、平盖、大麦芽等原料加入到清洗池中,对原料进行清洗,晾干后得到洁净的原料;
S2.中药药液的获取:分别称取清洗后的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、大麦芽15-30份,加入锅中,然后加入饮用水,煎煮得到中药药液;
S3.药品混合:将煎煮得到的中药药液加入到搅拌机中,然后再向搅拌机中加入维生素U0.5-1.5份、壳聚糖1-2份,搅拌10-30min,得到混合药品;
S4.成品的获取:将准备好的混合药品分装到药品袋中,密封后得到成品。
进一步的,上述步骤S1的具体步骤如下:
(1.1)分别将山药、柴胡、川芎、神曲、云苓、鸡内金、人参、黄芪、红枣、鬼针草、紫苜蓿、五味子、陈皮、佛手、桑黄、半枝莲、平盖、大麦芽等原料加入到清洗池中,对原料进行清洗;
(1.2)通过人工拣选的方式对清洗后的原料进行拣选,去除腐烂、变质的部分;
(1.3)将拣选后的原料自清洗池中捞出,放置到筛板上,晾干水分;
(1.4)将晾干后的原料放入烘干机中,烘干15-30min,得到洁净的原料,烘干温度为20-30摄氏度。
进一步的,上述步骤S2的具体步骤如下:
(1.1)称取以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、大麦芽15-30份作为中药原材料;
(1.2)将准备好的中药原材料加入到容器中,加入没过中药要材料的饮用水浸泡20-30min,所加入饮用水的温度为10-20摄氏度;
(1.3)将浸泡后的中药原材料连同浸泡中药原材料的水一并加入到锅中大火煮开后改小火煎煮10-15min,得到一煎药,然后将锅中的一煎药倒入容器中,将一煎药药渣保留在锅中;
(1.4)向保留了一煎药药渣的锅中加入没过一煎药药渣的饮用水,大火煮开后改小火煎煮5分钟,得到二煎药,然后将锅中的二煎药倒入容器中,将二煎药药渣保留在锅中,所加入的饮用水的温度为80-90摄氏度;
(1.5)将锅中保留的二煎药药渣放至室温后加入饮用水浸泡10分钟,大火煮开后改小火慢煎5分钟,得到三煎药,然后将锅中的三煎药倒入容器中,将锅中的三煎药药渣丢弃,所加入的饮用水与二煎药药渣的体积比为1:2,所加饮用水的温度为80-90摄氏度;
(1.6)将准备好的一煎药、二煎药和三煎药加入到搅拌机中,搅拌10-15min后得到中药药液。
山药性平、味甘、无毒,归脾、肺、肾经。山药具有滋养强壮、助消化、敛虚汗、止泻之功效,主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、遗精、妇女带下及消化不良的慢性肠炎。山药最适宜与灵芝搭配服用,具有防治糖尿病的作用。山药中含有丰富的粗蛋白质、粗纤维、淀粉、糖、钾、磷、钙、镁、灰分、铁、锌、铜、锰等营养物质,人类所需的18种氨基酸中,山药中含有16种。山药具有诱导产生干扰素,增强人体免疫功能的作用。其所含胆碱和卵磷脂有助于提高人的记忆力,具有健身强体、延缓衰老的功效。山药所含的能够分解淀粉的淀粉糖化酶,是萝卜中含量的3倍,胃胀时食用,有促进消化的作用,可以去除不适症状,有利于改善脾胃消化吸收功能。山药含有黏蛋白、淀粉酶、皂苷、游离氨基酸、多酚氧化酶等物质,且含量较为丰富,具有滋补作用,为病后康复食补之佳品,有强健机体、滋肾益精的作用。山药含有皂苷、黏液质,有润滑、滋润的作用,故可益肺气、养肺阴,治疗肺虚痰嗽久咳之症。山药几乎不含脂肪,而且所含的黏蛋白能预防心血管系统的脂肪沉积,防止动脉过早地发生硬化。山药含有皂苷能够降低胆固醇和甘油三酯,对高血压和高血脂等病症有改善作用。
柴胡味辛、苦,性微寒,归肝、胆、肺经。柴胡具有和解少阳、舒肝和胃、升阳举陷、治寒热往来、胸满胁痛、口苦耳聋、头痛目眩、疟疾、下利脱肛、月经不调、子宫下垂、热入血室等功效。此外,柴胡还具有解热、退热作用、镇静、镇痛、有解除胸闷胀痛、开郁调经等作用,柴胡还具有抗菌作用,对结核杆菌有抑制作。柴胡还具有抗肝损伤、抗病毒的作用,对流感病毒有强烈的抑制作用,对第1型脊髓灰白质炎病毒引起的细胞病变具有抑制作用。
川芎味辛、性温,入肝、胆经,具有行气开郁、祛除风燥湿、活血止痛等功效。川芎有明显的镇静作用。川芎挥发油少量时对动物大脑的活动具有抑制作用,而对延脑呼吸中枢、血管运动中枢及脊髓反射中枢具有兴奋作用。川芎煎剂分别给大、小鼠ig均能抑制其自发活动,使戊巴比妥钠引起的小鼠睡眠时间延长,并能对抗咖啡因(20mg/kg)的兴奋作用。但不能对抗戊四氮所致的大鼠惊厥。用川芎煎剂25-50g/kg灌胃,能抑制大鼠的自发活动,对小鼠的镇静较大鼠更明显,它还能延长戊巴比妥的睡眠时间。川芎对大肠、痢疾(宋内氏)、变形、绿脓、伤寒、副伤寒杆菌及霍乱弧菌等有抑制作用。川芎水浸剂(1:3)在试管内对某些致病性皮肤真菌也有抑制作用。川芎煎剂对动物放射病实验治疗有一定的疗效。川芎水溶性粗制剂对大鼠、小鼠及犬的放射线照射与氮芥损伤均有保护作用。
神曲味甘、辛、性温,归脾、胃经,具有健脾和胃、消食化积等作用。神曲为酵母制剂,含酵母菌,淀粉酶,维生素B复合体,麦角甾醇,蛋白质及脂肪,挥发油等,含多量酵母菌和B族维生素。神曲具有B族维生素样作用,具有增进食欲、维持正常消化机能等作用。神曲能够促进消化液的分泌,但可使正常小鼠小肠推进率降低,对肠运动呈现抑制效应。神曲及其复方制剂具有扶植双歧杆菌等有益菌生长、抑制肠杆菌等非专性厌氧菌增殖的作用,同时,神曲及其复方制剂可身高回肠组织中超氧化物歧化酶、一氧化氮、黄嘌呤氧化酶等水平,降低丙二醛的浓度,具有调整脾虚小鼠肠道菌群失调的作用,减少氧化自由基对机体损伤的能力。
云苓性平淡、味甘和、无毒性,归心、肺、脾经。云苓可以健脾、安神、镇静、利尿,也能促进身体免疫能力,云苓常用于治疗益气安神、健脾和胃、祛除湿热、行水止泄、治疗气虚劳伤、心腹胀满、水肿、腹泻、健忘、失眠等症。云苓的主要生物活性成分含茯苓酸、层孔酸、去氢层孔酸、松苓酸等三类化合物和茯苓聚糖等多种成分。具有抗发炎、抗氧化、调节免疫、镇静、止吐等作用。云苓菌核中含有大量的β-茯苓聚糖,还有茯苓酸、齿孔酸、块苓酸、松苓酸等。此外还含麦角甾醇、胆碱、腺嘌呤、卵磷脂等。
鸡内金味甘、性平,归脾、胃、小肠、膀胱经,具有健胃消食、涩精止遗、通淋化石等作用,常用于用于食积不消、呕吐泻痢、小儿疳积、遗尿、遗精、石淋涩痛、胆胀胁痛等症。鸡内金含胃激素、角蛋白、微量胃蛋白酶、淀粉酶和多种维生素。
人参味甘、微苦,性温、平,归脾、肺经、心经。具有补气、固脱、生津、安神、益智等功效,常用于治疗气短喘促、心悸健忘、口渴多汗、食少无力、一切急慢性疾病及失血后引起的休克、虚脱等症。还用于治劳伤虚损、食少、倦怠、反胃吐食、大便滑泄、虚咳喘促、自汗暴脱、惊悸、健忘、眩晕头痛、阳痿、尿频、消渴、妇女崩漏、小儿慢惊、及久虚不复、一切气血津液不足之症。人参对中枢神经系统具有兴奋作用,而大量时反而有抑制作用。能加强动物高级神经活动的兴奋和抑制过程。并能增强机体对一切非特异性刺激的适应能力,能减少疲劳感。
人参能调节中枢神经系统兴奋过程和抑制过程的平衡。人参可改变机体的反应性,与刺五加、北五味子等相似,具有“适应原”样作用,即能增强机体对各种有害刺激的反应能力,加强机体适应性。作为机体功能的调节剂,人参茎叶皂甙和根皂甙对物理性的(寒冷、过热、剧烈活动、放射线)、生物学性的(异体血清、细菌、移植肿瘤)、化学性的(毒物、麻醉药、激素、抗癌药等)种种刺激引起的应激反应均有保护作用,能使紊乱的机能恢复正常。同时,人参还能增强人体的免疫力。人参所含的总皂甙具抗菌、抗病毒及提高免疫力作用,对感染所致的胃粘膜损伤有效,具有较好的保护胃粘膜作用。
黄芪味甘、性微温,具有10大功能及营养价值:1、益气固表;2、敛汗固利尿消肿;4、托痰排脓:5、调节血压;6、增强免疫功能7、保肝护肝:8、强心;9、多营养价值丰富:10、黄芪炎糖能促进RNA和蛋白质合成,使细胞生长旺盛,寿命长,并能抗疲劳,抗流感病毒,黄芪多糖,皂苷对造血功能有保护作用和缺血心肌。具有增强机体免疫、保肝、利尿、抗衰老、抗应激、降压、补气固表、托毒排脓、利尿、生肌和较广泛的抗菌作用。黄芪与党参配合使用增强抵抗力的功效尤为显著。黄芪含6-二甲氧基异黄酮、胆碱、甜菜碱、氨基酸、蔗糖、葡萄糖醛酸及微量的叶酸。其中,6-二甲氧基异黄酮具有很强的抗氧化能力,可改善血液循环、降低胆固醇、抑制炎性生物酶的渗出,可以增进伤口愈合和止痛;胆碱是构成生物膜的重要组成成分,能促进脂肪代谢,增加瘦肉率,促进体内转甲基代谢;甜菜碱能促进脂肪代谢、提高瘦肉率,防止脂肪肝、增强机体免疫力。
红枣味甘性温,含有蛋白质、糖类、有机酸、维生素A、维生素C、多种微量钙以及氨基酸等丰富的营养成份。红枣能提高人体免疫力,并可抑制癌细胞,红枣能促进白细胞的生成,降低血清胆固醇,提高血清白蛋白,保护肝脏,红枣中还含有抑制癌细胞,甚至可使癌细胞向正常细胞转化的物质。红枣含有三萜类化合物及环磷酸腺苷,有较强的抑癌、抗过敏作用。大枣含有大量的糖类物质,主要为葡萄糖,还含有果糖、蔗糖及由葡萄糖和果糖组成的低聚糖、阿拉伯聚糖及半乳醛聚糖等;并含有大量的维生素C、核黄素、硫胺素、胡萝卜素、尼克酸等多种维生素。具有较强的补养作用,能提高人体免疫功能,增强抗病能力。
鬼针草性温、味苦、无毒,全草均可入药,具有清热、解毒、散瘀、消肿等功效。常用于阑尾炎、肾炎、胆囊炎、肠炎、细菌性痢疾、肝炎、腹膜炎、上呼吸道感染、扁桃体炎、喉炎、闭经、烫伤、毒蛇咬伤、跌打损伤、皮肤感染、小儿惊风、疳积等症。鬼针草具有良好的抗炎作用,鬼针草中的聚乙炔类化合物能明显抑制巴豆油诱发的小鼠耳廓肿胀及蛋清性足肿胀,降低大鼠棉球肉芽肿重量,还能显著抑制小鼠毛细血管通透性和醋酸致炎大鼠的白细胞游走。鬼针草中的黄酮结晶也有较好的抗炎作用。
鬼针草还具有镇静镇痛的作用,与氯丙嗪呈协同作用,与苯丙胺有拮抗作用。鬼针草皮下注射能明显减少大鼠胃液分泌量,降低胃液pH值、游离酸浓度,抑制小鼠肠道对炭末的推进作用,对大鼠实验性胃溃疡有保护作用,并能降低小鼠应激性溃疡的发生率。此外鬼针草还具有抗癌作用,鬼针草的多种提取物对体外培养的HL60、V937白血病细胞均有不同程度的抑制作用,其中以聚乙炔类化合物作用最佳。鬼针草和小花鬼针草混合水浸膏灌胃可明显降低雄性大鼠Ch和β脂蛋白,给大鼠静脉注射可明显抑制实验性动脉血栓形成,具有降血脂及抗血栓的作用。
紫苜蓿味甘、淡,性微寒。能清胃热,利尿除湿。紫苜蓿中含皂甙、卢瑟醇、紫苜蓿酚、大豆黄酮、紫苜蓿素、瓜氨酸、β-甲基-葡萄糖甙、蛋白质、糖等物质。从紫苜蓿中提出的苜蓿素,对实验动物小肠有抑制作用;尚有轻度抗氧化作用,可防止肾上腺素氧化,并有轻度雌激素样作用。全草提取物能抑制结核杆菌的生长,并对小鼠脊髓灰白质炎有效。紫苜蓿中提出的苜蓿素对离体豚鼠肠管有松弛作用。苜蓿素能抑制离休兔小肠之收缩,4mg苜蓿素注入在位兔小肠腔,可使蠕动收缩减慢。甲基苜蓿素本身对离体兔小肠无明显作用,但如先加入浴管中,可轻度拮抗苜蓿素的作用。苜蓿素尚有轻度的抗氧化作用,可防止肾上腺素的氧化。苜蓿的营养价值很高、每百克鲜品含蛋白质5.9克、碳水化合物9.7克、胡萝卜素3.28毫克、维生素C92毫克、维生素B20.36毫克、钙332毫克、磷115毫克、铁8毫克,另外还含有止血作用的维生素K。
五味子具有敛肺、滋肾、生津、收汗、涩精,常用于治疗肺虚喘咳、口干作渴、自汗、盗汗、劳伤羸瘦、梦遗滑精、久泻久痢等症。五味子醇提取物能降低由四氯化碳、硫代乙醇胺等引起的实验动物谷丙转氨酶升高。γ-五味子素(五味子乙素)具抗肝损伤作用。五味子素有广泛的中枢抑制作用,并且有安定作用的特点。五味子有强心作用,其水浸液及稀醇浸液,可加强心肌收缩力,增加血管张力。煎剂离体实验对大鼠心肌细胞膜ATP酶活性有抑制作用;并对麻醉犬有降压作用。五味子能增强机体对非特异性刺激的防御能力。五味子的乙醇浸液在体外对炭疽杆菌、金黄色葡萄球菌、白色葡萄球菌、伤寒杆菌、霍乱弧菌等均有抑制作用。
陈皮味苦、辛,性温,归肺、脾经。具有理气健脾、燥湿化痰的作用,常用于脘腹胀满、食少吐泻、咳嗽痰多等症。陈皮所含挥发油,对胃肠道有温和的刺激作用,可促进消化液的分泌,排除肠管内积气,显示了芳香健胃和驱风下气的效用。陈皮煎剂、醇提物等能兴奋心肌,但剂量过大时反而出现抑制。另外,它还可使血管产生轻度的收缩,迅速升高血压。陈皮中的果胶对高脂饮食引起的动脉硬化也有一定的预防作用。陈皮所含挥发油有刺激性被动祛痰作用,使痰液易咯出。陈皮煎剂对支气管有微弱的扩张作用。其醇提物的平喘效价较高。陈皮煎剂可使肾血管收缩,使尿量减少。陈皮煎剂与维生素C、维生素K并用,能增强消炎作用。
佛手味辛、苦、酸,性温,归肝、脾、胃、肺经,具有疏肝理气,和胄止痛,燥湿化痰的功效。佛手可促进消化液的分泌,还有促泻下作用。佛手的醇提取物对正常大鼠、兔的离体肠管及麻醉猫、兔的在体肠管均有显著的解痉作用,还能迅速缓解氨甲酰胆碱所致的麻醉猫胃、肠、胆囊张力增加。能明显抑制Ach引起的兔十二指肠痉挛,但对BaCl2引起的痉挛抑制作用较差。佛手能增加冠脉血流量,抑制心肌收缩力,减慢心率,降低血压,提高小鼠耐缺氧能力,对实验性心肌缺血、心律失常有保护作用。佛手醇提取物腹腔注射能明显减少小鼠自发活动,延长戊巴比妥睡眠时间,还有一定的镇痛作用和抗惊厥作用。佛手中的香叶木苷对角叉菜胶所致的大鼠足跖肿胀有抑制作用,还有维生素P、维生素C样作用,能降低兔毛细血管的渗透性,增强豚鼠毛细血管的抵抗力,减少肾上腺对维生素C的消耗。佛手中的橙皮苷对流感病毒、小疱性口炎病毒有抗病毒活性,还有抑制大鼠眼晶状体醛还原酶和预防冻伤的作用。佛手有一定的抗凝血和止血作用。
桑黄味微苦、性寒,具有活血、止血、化饮、止泻等功效,可用于治疗血崩、血淋、脱肛泻血、带下、经闭、症瘕积聚、癖饮、脾虚泄泻。具有抑制汗腺分泌、抗肿瘤、抗癌、抗纤维化、抗氧化、镇痛、抗菌、调节免疫的作用。桑黄的抗癌作用主要通过强化免疫、诱导癌细胞自行死亡,抑制癌细胞的增值和转移,减轻化疗和放疗的副作用,缓解癌症患者特有的疼痛,阻止溃疡、息肉、良性肿瘤等恶变为癌症,预防、避免癌症复发实现的。
半枝莲味辛、性平,富含红花素、异红花素、高山黄芩素、高山黄钤甙、β-谷甾醇、硬脂酸、生物碱多糖等,具有清热解毒、活血化瘀、消肿止痛、抗癌之功效,治阑尾炎、肝炎、胃痛、早期肝癌、肺癌、子宫颈癌、乳腺炎等,外用治痛疖疗、跌打肿痛等症。具清热解毒,化瘀利尿,用于疗疮肿毒等功效,半枝莲具有抑瘤作用,对急性粒细胞型白血病细胞有很轻度的抑制作用,对急性粒细胞型白血病血细胞的抑制率大于75%。半枝莲所含的黄芩素甙有增加脑血流量,降低脑血管阻力,提高血脑屏障通透性,以及对抗由二磷酸腺工苷引起的血小板凝聚的作用。
平盖即平盖灵芝,味微苦、性平,具有增强人体免疫功能、消除疲劳、保肝护肝、抑制癌细胞生长、提高睡眠质量、排肠毒、美容、滋补强身以及止痛、清热、化积、止血、化痰、安神的功效,主治食管癌、肺癌、肝癌、鼻咽癌、胰腺癌、急慢性肝炎、早期肝硬化、神经衰弱、肠风泻血、消化不良、风湿性肺结核等,平盖灵芝含有丰富的麦角甾醇、灵芝酸、灵芝多糖、氨基酸、多肽、腺苷、三萜类及多种微量元素和大量的有机锗,有机硒含量也很高。平盖灵芝所含的灵芝多糖在免疫系统中,在特殊的多糖成分中,通过增加抗体,诱导干扰素,增加防御性杀伤细胞,保护人体健康,增强免疫系统,在免疫系统中发挥作用。平盖灵芝所含的有机锗可刺激人体防御性的杀手细胞,帮助消灭异常细胞(如癌细胞)与病毒,以捍卫人体健康。有机锗和借由修正免疫系统中的某些缺失,以减少不正常的自体免疫疾病发生,另外有机锗可促进红血球的带氧能力,使组织细胞获得充足的氧气,因而加强了细胞的正常代谢、防止细胞衰老。
维生素U又称氯化甲硫氨基酸,氯化甲硫氨基酸这是一种抗溃疡剂,主要用于治疗胃溃疡和十二指肠溃疡,它并不是人体必需的营养素。维生素U存在于卷心菜、白菜、甘蓝、莴苣、苜蓿等绿叶蔬菜中,可由蛋氨酸与碘甲烷反应制得,有特殊气味,味咸苦。光照或久置空气中都不稳定。易溶于水,不溶于乙醇和乙醚,水溶液呈酸性。维生素U具有修复胃粘膜的作用。
壳聚糖又称脱乙酰甲壳素,是由自然界广泛存在的几丁质经过脱乙酰作用得到的,化学名称为聚葡萄糖胺(1-4)-2-氨基-B-D葡萄糖。首先,壳聚糖抑制那些助于脂肪吸收的脂肪酶的活性。脂肪酶分解脂肪使人体进行吸收。另外一个是排泄胆酸。一旦胆酸排泄,则血液中的胆固醇被用于制造胆酸。这两种机制使得壳聚糖成为强胆固醇清除剂。由于壳聚糖与胃酸作用后形成胶状液,附着在胃壁上形成保护膜,阻止了胃酸对损伤面的刺激,促进损伤面的修复,故壳聚糖可作为双低聚糖和猴头菇多糖,同时具有调节肠道菌群和辅助保护胃粘膜两大功效。
大麦芽味甘、性平,归脾、胃经,具有行气消食、健脾开胃、回乳消胀等功效,用于食积不消、脘腹胀痛、脾虚食少、乳汁郁积、乳房胀痛、妇女断乳、肝郁胁痛、肝胃气痛等症。大麦中含有淀粉酶、转化糖酶、尿囊素、蛋白质分解酶等,大麦有补胃消食、宽胸破积、舒气止泻之效。大麦中的尿素囊可促进胃肠道溃疡的愈合。大麦芽作用同大麦,两者常被选用作为保护胃粘膜作用的保健食品的原料。
本发明的有益效果为:
本发明的配方具有促进消化、缓解胃胀、镇痛、消炎、促进胃粘膜再生、保护胃粘膜、抑菌、增强免疫力等作用。本发明的配方在传统中药的基础上添加了维生素U、壳聚糖,用于促进胃粘膜的再生和保护胃粘膜,提高了药品对于胃的保护作用,有利于病灶的去除,提高药效,取得更好的治疗效果。同时本发明的配方还能缓解疼痛,有利于减轻患者在患病过程中所遭受的痛苦,有利于减轻病人的心理压力,有利于疾病的恢复。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。
实施例1:
本实施例提供一种治疗胃炎的中药配方,包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份。
实施例2:
本实施例提供一种治疗胃炎的中药配方,包括以重量份计算的山药85份、柴胡30份、川芎25份、神曲37份、云苓19份、鸡内金15份、人参25份、黄芪35份、红枣55份、鬼针草26份、紫苜蓿36份。
实施例3:
本实施例提供一种治疗胃炎的中药配方,包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份。
实施例4:
本实施例提供一种治疗胃炎的中药配方,包括以重量份计算的山药78份、柴胡33份、川芎25份、神曲42份、云苓18份、鸡内金15份、人参25份、黄芪46份、红枣58份、鬼针草25份、紫苜蓿40份、五味子15份、陈皮13份、佛手28份。
实施例5:
本实施例提供一种治疗胃炎的中药配方,山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份。
实施例6:
本实施例提供一种治疗胃炎的中药配方,山药82份、柴胡35份、川芎28份、神曲42份、云苓15份、鸡内金15份、人参24份、黄芪40份、红枣58份、鬼针草25份、紫苜蓿45份、五味子15份、陈皮13份、佛手25份、桑黄25份、半枝莲24份、平盖12份。
实施例7:
本实施例提供一种治疗胃炎的中药配方,包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、维生素U0.5-1.5份、壳聚糖1-2份、大麦芽15-30份。
本实施例的一种治疗胃炎的中药配方的制备方法,具体制备步骤如下:
(1)将山药、柴胡、川芎、神曲、云苓、鸡内金、人参、黄芪、红枣、鬼针草、紫苜蓿、五味子、陈皮、佛手、桑黄、半枝莲、平盖、大麦芽等原料加入到清洗池中,对原料进行清洗;
(2)通过人工拣选的方式对清洗后的原料进行拣选,去除腐烂、变质的部分;
(3)将拣选后的原料自清洗池中捞出,放置到筛板上,晾干水分;
(4)将晾干后的原料放入烘干机中,烘干20min,得到洁净的原料,烘干温度为25摄氏度;
(5)称取以重量份计算的洁净的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、大麦芽15-30份作为中药原材料;
(6)将准备好的中药原材料加入到容器中,加入没过中药要材料的饮用水浸泡30min,所加入饮用水的温度为15摄氏度;
(7)将浸泡后的中药原材料连同浸泡中药原材料的水一并加入到锅中大火煮开后改小火煎煮15min,得到一煎药,然后将锅中的一煎药倒入容器中,将一煎药药渣保留在锅中;
(8)向保留了一煎药药渣的锅中加入没过一煎药药渣的饮用水,大火煮开后改小火煎煮5分钟,得到二煎药,然后将锅中的二煎药倒入容器中,将二煎药药渣保留在锅中,所加入的饮用水的温度为80摄氏度;
(9)将锅中保留的二煎药药渣放至室温后加入饮用水浸泡10分钟,大火煮开后改小火慢煎5分钟,得到三煎药,然后将锅中的三煎药倒入容器中,将锅中的三煎药药渣丢弃,所加入的饮用水与二煎药药渣的体积比为1:2,所加饮用水的温度为80摄氏度;
(10)将准备好的一煎药、二煎药和三煎药加入到搅拌机中,搅拌12min后得到中药药液;
(11)将煎煮得到的中药药液加入到搅拌机中,然后再向搅拌机中加入维生素U0.5-1.5份、壳聚糖1-2份,搅拌15min,得到混合药品;
(12)将准备好的混合药品分装到药品袋中,密封后得到成品。
实施例8:
本实施例提供一种治疗胃炎的中药配方,包括以重量份计算的山药83份、柴胡35份、川芎25份、神曲42份、云苓17份、鸡内金15份、人参23份、黄芪40份、红枣54份、鬼针草23份、紫苜蓿41份、五味子15份、陈皮15份、佛手25份、桑黄26份、半枝莲25份、平盖8份、维生素U1份、壳聚糖1.5份、大麦芽25份。
本发明不局限于上述可选的实施方式,任何人在本发明的启示下都可得出其他各种形式的产品。上述具体实施方式不应理解成对本发明的保护范围的限制,本发明的保护范围应当以权利要求书中界定的为准,并且说明书可以用于解释权利要求书。
Claims (10)
1.一种治疗胃炎的中药配方,其特征在于:包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份。
2.根据权利要求1所述的一种治疗胃炎的中药配方,其特征在于:所述治疗胃炎的中药配方还包括五味子份、陈皮份和佛手份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份。
3.根据权利要求2所述的一种治疗胃炎的中药配方,其特征在于:所述治疗胃炎的中药配方还包括桑黄份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份。
4.根据权利要求3所述的一种治疗胃炎的中药配方,其特征在于:所述治疗胃炎的中药配方还包括半枝莲份、平盖份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份。
5.根据权利要求4所述的一种治疗胃炎的中药配方,其特征在于:所述治疗胃炎的中药配方还包括维生素U份、壳聚糖份和大麦芽份,所述治疗胃炎的中药配方包括以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、维生素U0.5-1.5份、壳聚糖1-2份、大麦芽15-30份。
6.根据权利要求1所述的一种治疗胃炎的中药配方,其特征在于:包括以重量份计算的山药85份、柴胡30份、川芎25份、神曲37份、云苓19份、鸡内金15份、人参25份、黄芪35份、红枣55份、鬼针草26份、紫苜蓿36份。
7.根据权利要求5所述的一种治疗胃炎的中药配方,其特征在于:所述治疗胃炎的中药配方还包括维生素U份、壳聚糖份和大麦芽份,所述治疗胃炎的中药配方包括以重量份计算的山药83份、柴胡35份、川芎25份、神曲42份、云苓17份、鸡内金15份、人参23份、黄芪40份、红枣54份、鬼针草23份、紫苜蓿41份、五味子15份、陈皮15份、佛手25份、桑黄26份、半枝莲25份、平盖8份、维生素U1份、壳聚糖1.5份、大麦芽25份。
8.一种治疗胃炎的中药配方的制备方法,其特征在于:制备权利要求5中所述的一种治疗胃炎的中药配方,具体制备步骤如下:
S1.原料清洗:分别将山药、柴胡、川芎、神曲、云苓、鸡内金、人参、黄芪、红枣、鬼针草、紫苜蓿、五味子、陈皮、佛手、桑黄、半枝莲、平盖、大麦芽等原料加入到清洗池中,对原料进行清洗,晾干后得到洁净的原料;
S2.中药药液的获取:分别称取清洗后的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、大麦芽15-30份,加入锅中,然后加入饮用水,煎煮得到中药药液;
S3.药品混合:将煎煮得到的中药药液加入到搅拌机中,然后再向搅拌机中加入维生素U0.5-1.5份、壳聚糖1-2份,搅拌10-30min,得到混合药品;
S4.成品的获取:将准备好的混合药品分装到药品袋中,密封后得到成品。
9.根据权利要求8所述的一种治疗胃炎的中药配方,其特征在于:所述步骤S1的具体步骤如下:
(1.1)分别将山药、柴胡、川芎、神曲、云苓、鸡内金、人参、黄芪、红枣、鬼针草、紫苜蓿、五味子、陈皮、佛手、桑黄、半枝莲、平盖、大麦芽等原料加入到清洗池中,对原料进行清洗;
(1.2)通过人工拣选的方式对清洗后的原料进行拣选,去除腐烂、变质的部分;
(1.3)将拣选后的原料自清洗池中捞出,放置到筛板上,晾干水分;
(1.4)将晾干后的原料放入烘干机中,烘干15-30min,得到洁净的原料,烘干温度为20-30摄氏度。
10.根据权利要求8或9所述的一种治疗胃炎的中药配方,其特征在于:所述步骤S2的具体步骤如下:
(1.1)称取以重量份计算的山药70-90份、柴胡30-45份、川芎20-30份、神曲40-60份、云苓10-20份、鸡内金10-20份、人参20-30份、黄芪30-50份、红枣50-60份、鬼针草20-30份、紫苜蓿30-50份、五味子10-20份、陈皮10-15份、佛手20-30份、桑黄20-30份、半枝莲20-30份、平盖5-20份、大麦芽15-30份作为中药原材料;
(1.2)将准备好的中药原材料加入到容器中,加入没过中药要材料的饮用水浸泡20-30min,所加入饮用水的温度为10-20摄氏度;
(1.3)将浸泡后的中药原材料连同浸泡中药原材料的水一并加入到锅中大火煮开后改小火煎煮10-15min,得到一煎药,然后将锅中的一煎药倒入容器中,将一煎药药渣保留在锅中;
(1.4)向保留了一煎药药渣的锅中加入没过一煎药药渣的饮用水,大火煮开后改小火煎煮5分钟,得到二煎药,然后将锅中的二煎药倒入容器中,将二煎药药渣保留在锅中,所加入的饮用水的温度为80-90摄氏度;
(1.5)将锅中保留的二煎药药渣放至室温后加入饮用水浸泡10分钟,大火煮开后改小火慢煎5分钟,得到三煎药,然后将锅中的三煎药倒入容器中,将锅中的三煎药药渣丢弃,所加入的饮用水与二煎药药渣的体积比为1:2,所加饮用水的温度为80-90摄氏度;
(1.6)将准备好的一煎药、二煎药和三煎药加入到搅拌机中,搅拌10-15min后得到中药药液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910093345.9A CN109568472A (zh) | 2019-01-30 | 2019-01-30 | 一种治疗胃炎的中药配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910093345.9A CN109568472A (zh) | 2019-01-30 | 2019-01-30 | 一种治疗胃炎的中药配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109568472A true CN109568472A (zh) | 2019-04-05 |
Family
ID=65918280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910093345.9A Pending CN109568472A (zh) | 2019-01-30 | 2019-01-30 | 一种治疗胃炎的中药配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109568472A (zh) |
-
2019
- 2019-01-30 CN CN201910093345.9A patent/CN109568472A/zh active Pending
Non-Patent Citations (1)
Title |
---|
林丽华等: "加味陈夏六君丸治疗脾胃气虚病证526例", 《湖南中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
CN102784363B (zh) | 一种治疗胰腺癌的中药组合物及其制备方法 | |
CN103416534B (zh) | 一种富硒养胃茶及其生产方法 | |
CN103652360B (zh) | 用于治疗猪副伤寒的饲料及其制备方法 | |
CN108244633A (zh) | 一种祛湿健脾的保健食品组合物及其制备方法 | |
KR100947278B1 (ko) | 하엽 추출물을 주성분으로 하는 탄수화물 및 지방 흡수억제 활성을 가지는 생약 조성물과 이의 제조 방법 | |
CN105230569A (zh) | 一种肉鸡饲养方法 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN108208456A (zh) | 一种提高蛋鸡产蛋率的饲料添加剂及其制备方法 | |
CN108244379A (zh) | 一种幼兔促生长的饲料添加剂及其制备方法 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN108464406A (zh) | 促进肉鸡生长、改善肉质风味的肉鸡饲料及其制备方法 | |
CN104186937A (zh) | 鱼出血病防治饲料 | |
CN109568472A (zh) | 一种治疗胃炎的中药配方及其制备方法 | |
CN105361149A (zh) | 一种青稞虫草糁子营养粉及其制备方法 | |
CN104905032A (zh) | 防治黄沙鳖肝炎的饲料添加剂 | |
CN108552432A (zh) | 一种提高蛋鸡产蛋率的蛋鸡饲料及其制备方法 | |
CN105147944B (zh) | 一种中药组合物、其制剂及其制备方法和应用 | |
CN108419941A (zh) | 一种家兔抗热应激饲料及其制备方法 | |
CN106889390A (zh) | 一种养胃保健饮料及其制备方法 | |
CN108185200A (zh) | 一种肉兔防病、促生长的饲料添加剂及其制备方法 | |
CN105918902A (zh) | 一种产后瘦身美白的牦牛脊骨药膳及制备方法 | |
CN104544125A (zh) | 具有提高人体免疫力的中药保健胶囊及制备方法 | |
CN117441892A (zh) | 一种具有消食导滞作用的食品及其制备方法 | |
CN104489729A (zh) | 防治肿瘤的鸽肉肠 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190405 |